Docket Text - Teva Pharmaceuticals USA, Inc. et al v. Synthon Pharmaceuticals, Inc. et al

Docket Text Information


	This may not be the most complete up-to-date docket information. For daily updates on this case, sign-up for a Lawsuit Tracker.

Date

Docket Text

4/4/2012

FINANCIAL DISCLOSURE STATEMENT by Teva Pharmaceuticals USA, Inc. identifying Corporate Parent Teva Pharmaceutical Industries Ltd. for Teva Pharmaceuticals USA, Inc... (Holland, Gregory) (Entered: 04/04/2012)

4/4/2012

COMPLAINT against Synthon B.V., Synthon Holding B.V., Synthon Pharmaceuticals, Inc., Synthon s.r.o. ( Filing fee $ 350 receipt number 0417-2012108.), filed by Teva Neuroscience, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Yeda Research and Development Co. Ltd.. (Attachments: # 1 Index to Exhibits, # 2 Exhibit A - Patent US 7,199,098 B2, # 3 Exhibit B - Patent US 6,939,539 B2, # 4 Exhibit C - Patent US 6,054,430, # 5 Exhibit D - Patent US 6,620,847 B2, # 6 Exhibit E - Patent US 5,981,589, # 7 Exhibit F - Patent US 6,342,476 B1, # 8 Exhibit G - Patent US 6,362,161 B1, # 9 Exhibit H - Patent US 5,800,808, # 10 Exhibit I - Patent US 6,048,898, # 11 Civil Cover Sheet) (Holland, Gregory) (Entered: 04/04/2012)

Email Address:
Password:
Remember Me:	Forgot your password?